Showing results (181-190 of 399) with videos related to
Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
The pharmacokinetics and toxicity of two application schedules with high-dose VP-16 in patients receiving an allogeneic bone marrow transplantationK Mross, J Reifke, P Bewermeier, et al.Seminars in Oncology|February 1, 1992
Phase II and III studies with carboplatin in small cell lung cancerU Gatzemeier, D K Hossfeld, R Neuhauss, et al.Cancer Genetics and Cytogenetics|July 1, 1988
Trisomy 4 in two cases of acute myelomonocytic leukemiaS Suciu, H J Weh, R Kuse, et al.Cancer Genetics and Cytogenetics|June 1, 1992
A case of adult ALL with +i(13q) as the sole anomalyT A Walter, U Müllerleile, I Galinke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancerU Gatzemeier, D K Hossfeld, R Neuhauss, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancerU Gatzemeier, M Heckmayr, D K Hossfeld, et al.Pneumologie (Stuttgart, Germany)|February 1, 1990
[Cisplatin-Vepeside versus Endoxan-Vepeside in the treatment of small cell bronchial cancer. A randomized study]M Heckmayr, U Gatzemeier, D K Hossfeld, et al.Oncology Reports|February 22, 2001
A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients with advanced colorectal cancerW Fiedler, W Krüger, E Laack, et al.Cancer Genetics and Cytogenetics|August 25, 1999
Unusual clinical course and acquisition of del(11)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemiaJ Dierlamm, M Stefanova, L Michaux, et al.Klinische Wochenschrift|April 4, 1991
A phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancerW Fiedler, W Zeller, C J Peimann, et al.Pageof 40